Physiological and pathological significance of mPOU, anovel transcription factor that amplifies prolactin gene expression

mPOU(一种放大催乳素基因表达的新型转录因子)的生理和病理意义

基本信息

  • 批准号:
    12671085
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

We previously cloned a transcription factor, mPOU, which binds pit-1 binding DNA elements of PRL gene, from human pituitary DNA library. To clarify physiological and pathological significance, we first examined the effect of mPOU on the gene expressions regulated by Pit-1 in transient expressions and luciferase reporter gene systems, mPOU and Pit-1 synergistically activated the prolactin (PRL) reporter gene expression, mPOU and pit-1 additively stimulated growth hormone (GH) gene expression. However, mPOU did not affect GH-releasing hormone receptor gene expression. The synergisticd activation mechanism of mPOU and Pit-1 on PRL gene expression is unknown. Next, to clarify whether PRL-or GH-producing cells in human pituitary adenomas have mPOU, serial sections of the specimen were analyzed with anti-hPRL anti-hGH and anti-mPOU antibodies. With anti-mPOU antiserum, PRL- and GH-producing cells yielded a strong signal that was located specifically over the nuclei. On the other hand, no signal was observed when non-functioning pituitary adenoma. Taken together, mPOU appeared to stimulate PRL and GH gene expressions in PRL- and GH- producing pituitary cells, although its pathological significance remained unknown. A targeting vector to knock out mouse Emb (mouse homologue of mPOU) is now being prepared. The Emb knock out mouse may reveal the physiological significance of mPOU.
我们以前从人垂体DNA文库中克隆了一个与PRL基因pit-1结合元件结合的转录因子mPOU。为了阐明mPOU的生理和病理意义,我们首先在瞬时表达和荧光素酶报告基因系统中检测了mPOU对Pit-1调控的基因表达的影响,mPOU和Pit-1协同激活催乳素(PRL)报告基因表达,mPOU和Pit-1相加刺激生长激素(GH)基因表达。然而,mPOU不影响GH释放激素受体基因的表达。mPOU和Pit-1协同激活PRL基因表达的机制尚不清楚。接下来,为了澄清人垂体腺瘤中的PRL或GH产生细胞是否具有mPOU,用抗hPRL、抗hGH和抗mPOU抗体分析标本的连续切片。与抗mPOU抗血清,PRL-和GH-生产细胞产生了强烈的信号,具体位于细胞核。而无功能垂体腺瘤则无信号。两者合计,mPOU似乎刺激PRL和GH基因表达的PRL和GH-生产垂体细胞,但其病理意义仍然未知。目前正在制备敲除小鼠Emb(mPOU的小鼠同源物)的靶向载体。Emb基因敲除小鼠可能揭示了mPOU的生理意义。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kaji H: "Bone metabolism and body composition in Japanese patients with active acromegaly"Clin Endocrinol(Oxf). 55. 175-181 (2001)
Kaji H:“日本活动性肢端肥大症患者的骨代谢和身体成分”Clin Endocrinol(Oxf)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Murata M: "Stimulation by eicosapentaenoie acids of leptin mRNA expression and its secretion in mouse 3T3-LI adipocytes in ritro"Biochem Biophys Res Commun. 270. 343-348 (2000)
Murata M:“二十碳五烯酸对小鼠 3T3-LI 脂肪细胞体外瘦素 mRNA 表达及其分泌的刺激”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kaji H: "Hormonal regulation of the human ghrelin receptor gene transcription"Biochem Biophys Res Commun. 286. 660-666 (2001)
Kaji H:“人类生长素释放肽受体基因转录的激素调节”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kaji H.: "Hormonal regulation of the human ghrelin receptor gene transcription"Biochem Biophys Res Commun. 284. 660-666 (2001)
Kaji H.:“人类生长素释放肽受体基因转录的激素调节”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Murata M: "Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells"J Biol Chem. 277. 5667-5674 (2002)
Murata M:“Ghrelin 调节肝癌细胞中胰岛素信号传导的下游分子”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKIMURA Yasuhiko其他文献

OKIMURA Yasuhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKIMURA Yasuhiko', 18)}}的其他基金

GH plays a role in the protective effect of BCAA against muscle atrophy
GH 在 BCAA 对抗肌肉萎缩的保护作用中发挥作用
  • 批准号:
    26500021
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of inductive effect of mPOU on PRL cell differentiation for future application for pituitary tumor treatment
mPOU对PRL细胞分化的诱导作用分析及其在垂体瘤治疗中的应用
  • 批准号:
    20591095
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cloning of the factors determining specific production of GH in somatotrophs and their pathophysiological significance
生长激素细胞GH特异性产生因子的克隆及其病理生理意义
  • 批准号:
    17590962
  • 财政年份:
    2005
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathogenesis of a transcription factor disease, combined pituitary hormone defficiency
转录因子疾病的发病机制,联合垂体激素缺乏
  • 批准号:
    14571065
  • 财政年份:
    2002
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of regulatory mechanism for gene exprssions of growth hormone-releasing peptide receptor and growth hormone-releasing hormone receptor
生长激素释放肽受体及生长激素释放激素受体基因表达调控机制分析
  • 批准号:
    09671059
  • 财政年份:
    1997
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

垂体Nestin阳性细胞多向分化潜能的研究
  • 批准号:
    30500248
  • 批准年份:
    2005
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding the role of the transcription factor Gli3 in Kallmann syndrome and normosmic forms of idiopathic hypogonadotropic hypogonadism.
了解转录因子 Gli3 在卡尔曼综合征和正常形式的特发性低促性腺激素性性腺功能减退症中的作用。
  • 批准号:
    10112936
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
Understanding the role of the transcription factor Gli3 in Kallmann syndrome and normosmic forms of idiopathic hypogonadotropic hypogonadism.
了解转录因子 Gli3 在卡尔曼综合征和正常形式的特发性低促性腺激素性性腺功能减退症中的作用。
  • 批准号:
    9892022
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
Understanding the role of the transcription factor Gli3 in Kallmann syndrome and normosmic forms of idiopathic hypogonadotropic hypogonadism.
了解转录因子 Gli3 在卡尔曼综合征和正常形式的特发性低促性腺激素性性腺功能减退症中的作用。
  • 批准号:
    10355446
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
Understanding the role of the transcription factor Gli3 in Kallmann syndrome and normosmic forms of idiopathic hypogonadotropic hypogonadism.
了解转录因子 Gli3 在卡尔曼综合征和正常形式的特发性低促性腺激素性性腺功能减退症中的作用。
  • 批准号:
    10570176
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
Functional analysis of zeb1/deltaEF1 transcription factor on posterior pituitary development in mouse
zeb1/deltaEF1转录因子对小鼠垂体后叶发育的功能分析
  • 批准号:
    17K09896
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Hematopoietic Transcription Factor Ikaros As a Metabolic Sensor in Neuroendocrine Cells
造血转录因子 Ikaros 作为神经内分泌细胞的代谢传感器
  • 批准号:
    223783
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
The Forkhead Transcription Factor, FOXO1, and its Role in Pituitary Gland Develop
叉头转录因子 FOXO1 及其在脑下垂体发育中的作用
  • 批准号:
    7820491
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
Analysis of function and regulatory mechanism of mRNA expression of bird specific transcription factor in the anterior pituitary gland
鸟类垂体前叶特异性转录因子mRNA表达的功能及调控机制分析
  • 批准号:
    19580330
  • 财政年份:
    2007
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of the transcription factor CREB in the regulation of cell proliferation in estrogen-responsive cells
转录因子CREB在雌激素反应性细胞增殖调节中的作用
  • 批准号:
    17590198
  • 财政年份:
    2005
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular aspect of in cell invasion by pituitary adenoma mediated by hypoxia-relating transcription factor
缺氧相关转录因子介导的垂体腺瘤细胞侵袭的分子方面
  • 批准号:
    17591536
  • 财政年份:
    2005
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了